Angiogenic growth factor secretion by mesenchymal stem cell

The entry "Angiogenic growth factor secretion by mesenchymal stem cell activity" does not refer to a single molecule or receptor but rather describes a **biological process** in which mesenchymal stem cells (MSCs) secrete multiple pro‐angiogenic factors. These secreted factors include vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), platelet-derived growth factor-BB (PDGF-BB), transforming growth factor-beta 1 (TGF‑β1), hepatocyte growth factor (HGF), interleukin 8, and others[2][6][1]. This paracrine activity is central to the ability of MSCs to promote new blood vessel formation in tissue repair, tumor progression, and regenerative medicine applications[2][5][6]. The process is not itself a therapeutic target but involves several well-characterized targets such as VEGF receptor and PDGFR. Therefore, this entry is **not a canonical molecular target** but an umbrella term for the collective action of various secreted proteins from MSCs that drive angiogenesis. > “Proteomic analysis showed that exosomes derived from MSCs contain growth factors such as VEGF, TGFB1, and interleukin‐8…contribute in their pro‐angiogenic activity”[2]. > “TGF‑β1 and PDGF‑BB may serve a crucial role in mediating gb‑MSC angiogenesis…providing a therapeutic strategy for targeting the angiogenic capacity of gb-MSCs”[1]. Because this term refers to an entire biological function rather than an individual protein or gene product with druggability or biomarker status on its own—and because it lacks specificity—it should be flagged as incorrect for use as a structured molecular target.

Other names

Mesenchymal stem cell angiogenic factor secretionMSC-mediated angiogenesisMSC paracrine pro-angiogenic activity